Online citations, reference lists, and bibliographies.
← Back to Search

Solid Lipid Nanoparticles As Carriers Of Hydrocortisone And Progesterone Complexes With β-cyclodextrins

R. Cavalli, E. Peira, O. Caputo, M. Gasco
Published 1999 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Inclusion complexes of hydrocortisone and progesterone were formed with β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin. The formation of the complexes was confirmed by differential scanning calorimetry (DSC). The inclusion complexes were incorporated in two types of solid lipid nanoparticles (SLN). In the presence of the complexes the sizes of SLN remained below 100 nm. DSC analysis showed that hydrocortisone and progesterone are dispersed in SLN in an amorphous state. Using the β-cyclodextrin complexes the incorporation of the more hydrophilic drug, hydrocortisone, was higher than that of progesterone. Release of hydrocortisone and progesterone from SLN was lower when they were incorporated as inclusion complexes than as free molecules.
This paper references
10.1002/JPS.2600810609
Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
T. Irie (1992)
10.1016/S0378-5173(98)00147-1
Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading
E. Lemos-Senna (1998)
10.1002/ARDP.19943271109
Complexation of Hydrocortison with β‐Cyclodextrin and Hydroxypropyl‐β‐Cyclodextrin
A. Preiss (1994)
10.1021/JS960213F
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation.
T. Irie (1997)
10.1016/0378-5173(94)90361-1
Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery
B. McCormack (1994)
10.1248/CPB.26.2832
Solubilization of steroid hormones by polyoxyethylene lauryl ether.
H. Tomida (1978)
10.3109/03639049009114894
Inclusion Complexation of 4-Biphenylacetic Acid with β-Cyclodextrin
G. Puglisi (1990)
The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules
R. Cavalli (1998)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
10.1016/S0378-5173(96)04822-3
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
R. Cavalli (1997)
10.1016/0378-5173(94)90155-4
The effect of water-soluble polymers on drug-cyclodextrin complexation
T. Loftsson (1994)
10.1063/1.1678153
Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants
D. Koppel (1972)
10.1021/JS960075U
Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.
R. Rajewski (1996)
Hydrocortisone/cyclodextrin complex. Complexation methods and complex incorporation in liposomes
M. Bećirević-Laćan (1997)
Study by X-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles
R. Cavalli (1995)
10.1016/0378-5173(82)90057-6
Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase
K. Uekama (1982)
10.1016/0378-5173(95)00098-4
Long acting injectable oxytetracycline-liposphere formulations
A. Domb (1995)



This paper is referenced by
10.1007/978-3-030-49308-0_7
Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery
A. Pandey (2020)
10.1016/j.nano.2010.12.002
A nanoemulsion formulation of dacarbazine reduces tumor size in a xenograft mouse epidermoid carcinoma model compared to dacarbazine suspension.
Srikanth Kakumanu (2011)
Design and Development of Solid Lipid Nanoparticles for Ocular Delivery of Acyclovir
A. Seyfoddin (2013)
10.1080/01932690701856782
Preparation, Characterization, and In Vitro Release of Chloramphenicol Loaded Solid Lipid Nanoparticles
X. W. Li (2008)
BRITISH BIOMEDICAL BULLETIN
U. Takalkar (2013)
10.1016/J.ADDR.2007.04.013
Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.
H. Bunjes (2007)
10.23893/1307-2080.aps.05713
Preparation and in vitro characterization of a fluconazole loaded chitosan particulate system
Gülsel Yurtdaş Kırımlıoğlu (2019)
10.1007/978-3-319-76162-6_2
Cyclodextrin-Steroid Interactions and Applications to Pharmaceuticals, Food, Biotechnology and Environment
É. Fenyvesi (2018)
10.1016/j.ijpharm.2017.05.033
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays.
F. Maestrelli (2017)
10.1016/j.ejps.2018.03.004
The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation
H. Lee (2018)
10.1007/S11483-008-9065-8
Solid Lipid Nanoparticles as Delivery Systems for Bioactive Food Components
J. Weiss (2008)
SOLID LIPID NANOPARTICLES- A NOVEL SOLID LIPID BASED TECHNOLOGY FOR POORLY WATER SOLUBLE DRUGS: A REVIEW
P. Shanmukhi (2013)
SOLID LIPID NANOPARTICLES: A NEW APPROACH OF COLLOIDAL DRUG CARRIER
Girish Kumar Parida (2016)
SELECTED DRUG DELIVERY SYSTEMS BASED ON NANOEMULSION
M. A. Elgadira (2014)
10.1517/17425240903222218
Recent advances and future directions in amphiphilic cyclodextrin nanoparticles
E. Bilensoy (2009)
CYCLODEXTRINS: NANOCARRIERS FOR NOVEL DRUG DELIVERY
Kishore Rapolu (2012)
CURRENT TRENDS IN β-CYCLODEXTRIN BASED DRUG DELIVERY SYSTEMS
Lala Rita (2011)
10.1039/d0ra03491f
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Yongtao Duan (2020)
CODEN: IJPNL6 CYCLODEXTRINS: NANOCARRIERS FOR NOVEL DRUG DELIVERY
Kishore Rapolu (2011)
10.1007/S10847-008-9456-Y
Cyclodextrin based novel drug delivery systems
Amber Vyas (2008)
10.1021/jp400509r
Cyclodextrin-complexation effects on the low-frequency vibrational dynamics of ibuprofen by combined inelastic light and neutron scattering experiments.
V. Crupi (2013)
10.1201/9781315114361-5
Chapter 4: Emerging Nanopharmaceuticals
Dhruba J. Bharali (2017)
10.2217/17435889.2.2.183
Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
A. F. Soares (2007)
Quantitative, Qualitative and In Vitro Evaluation of Solid Lipid Nanoparticles Containing 5-Fluorouracil
Mohamed S. Majrad (2014)
10.1358/MF.2005.27.2.876286
Solid lipid nanoparticles as drug delivery systems.
K. Manjunath (2005)
10.2147/IJN.S28307
Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide
John Youshia (2012)
Importan ce of Solid L ipid Nanoparti
(2011)
10.1155/2012/750891
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
P. Severino (2012)
Ciclodextrinas em novos sistemas terapeuticos
Rui Saltão (2001)
NANOSTRUCTURE LIPID CARRIERS (NLC) FOR TOPICAL APPLICATION: A REVIEW
Gajanan Y. Shinde (2013)
10.1007/978-94-017-0948-4_8
Brassinosteroids and Brassinosteroid Analogues Inclusion Complexes in Cyclodextrins
M. A. Zullo (2003)
10.1016/J.ADDR.2006.09.017
Freeze-drying of nanoparticles: formulation, process and storage considerations.
W. Abdelwahed (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar